Literature DB >> 23922202

Early light reduction for preventing retinopathy of prematurity in very low birth weight infants.

Eliane C Jorge1, Edson N Jorge, Regina P El Dib.   

Abstract

BACKGROUND: Retinopathy of prematurity (ROP) is a complex condition of the developing retinal blood vessels and is one of the leading causes of preventable childhood blindness. Several risk factors for ROP have been studied over the past 50 years. Among them, general immaturity (low birth weight and low gestational age) and prolonged oxygen therapy have been consistently related to disease onset. However, it is understood that the progression of the disease is multifactorial and may be associated with others risk factors, such as multiple gestation, apnoea, intracranial haemorrhage, anaemia, sepsis, prolonged mechanical ventilation, multiple transfusions and light exposure. Furthermore, the precise role of these individual factors in the development of the disease has not yet been well established.
OBJECTIVES: To determine whether the reduction of early environmental light exposure reduces the incidence of retinopathy of prematurity (ROP) or poor ROP outcomes among very low birth weight infants. SEARCH
METHODS: We searched the following databases: the Cochrane Neonatal Group Specialised Register, CENTRAL (The Cochrane Library), MEDLINE, EMBASE, CINAHL, HealthSTAR, Science Citation Index Database, CANCERLIT, the Oxford Database of Perinatal Trials and www.clinicaltrials.gov. We also searched previous reviews including cross-references, abstracts, conference and symposia proceedings, and contacted expert informants. This search was updated in October 2012. SELECTION CRITERIA: Randomised or quasi-randomised controlled trials that reduced light exposure to premature infants within the first seven days following birth were considered for this review. We also considered cluster-randomised controlled trials. DATA COLLECTION AND ANALYSIS: Data on clinical outcomes including any acute ROP and poor ROP outcome were extracted by both review authors independently and consensus reached. We conducted data analysis according to the standards of the Cochrane Neonatal Review Group. MAIN
RESULTS: Data from four randomised trials with a total of 897 participants failed to show any reduction in acute ROP or poor ROP outcome with the reduction of ambient light to premature infants' retinas. The overall methodological quality of the included studies was about evenly split between those in which the classification was unclear and those in which the studies were categorised as low risk of bias. There was no report on the secondary outcomes considered in this review: quality of life measures; and time of exposure to oxygen. AUTHORS'
CONCLUSIONS: The evidence shows that bright light is not the cause of retinopathy of prematurity and that the reduction of exposure of the retinas of premature infants to light has no effect on the incidence of the disease.

Entities:  

Mesh:

Year:  2013        PMID: 23922202      PMCID: PMC7045419          DOI: 10.1002/14651858.CD000122.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  29 in total

Review 1.  Early light reduction for preventing retinopathy of prematurity in very low birth weight infants.

Authors:  D L Phelps; J L Watts
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 2.  The International Classification of Retinopathy of Prematurity revisited.

Authors: 
Journal:  Arch Ophthalmol       Date:  2005-07

3.  Retrolental fibroplasia and light.

Authors:  W R HEPNER; A C KRAUSE; M E DAVIS
Journal:  Pediatrics       Date:  1949-06       Impact factor: 7.124

4.  An international classification of retinopathy of prematurity. II. The classification of retinal detachment. The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity.

Authors: 
Journal:  Arch Ophthalmol       Date:  1987-07

5.  Pathogenesis of retrolental fibroplasia.

Authors:  P A Riley; T F Slater
Journal:  Lancet       Date:  1969-08-02       Impact factor: 79.321

6.  Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.

Authors:  Helen A Mintz-Hittner; Kathleen A Kennedy; Alice Z Chuang
Journal:  N Engl J Med       Date:  2011-02-17       Impact factor: 91.245

7.  Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity.

Authors:  A Hellstrom; C Perruzzi; M Ju; E Engstrom; A L Hard; J L Liu; K Albertsson-Wikland; B Carlsson; A Niklasson; L Sjodell; D LeRoith; D R Senger; L E Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

Review 8.  Pathogenesis of retinopathy of prematurity.

Authors:  Lois E H Smith
Journal:  Semin Neonatol       Date:  2003-12

9.  Effect of bright light in the hospital nursery on the incidence of retinopathy of prematurity.

Authors:  P Glass; G B Avery; K N Subramanian; M P Keys; A M Sostek; D S Friendly
Journal:  N Engl J Med       Date:  1985-08-15       Impact factor: 91.245

10.  Effect of light on oxygen-induced retinopathy in the mouse.

Authors:  E Wesolowski; L E Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-01       Impact factor: 4.799

View more
  6 in total

Review 1.  Advances in understanding and management of retinopathy of prematurity.

Authors:  Mary Elizabeth Hartnett
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

2.  Timing for the Introduction of Cycled Light for Extremely Preterm Infants: A Randomized Controlled Trial.

Authors:  Debra H Brandon; Susan G Silva; Jinhee Park; William Malcolm; Heba Kamhawy; Diane Holditch-Davis
Journal:  Res Nurs Health       Date:  2017-04-21       Impact factor: 2.228

Review 3.  The neural retina in retinopathy of prematurity.

Authors:  Ronald M Hansen; Anne Moskowitz; James D Akula; Anne B Fulton
Journal:  Prog Retin Eye Res       Date:  2016-09-23       Impact factor: 21.198

Review 4.  The progress of prophylactic treatment in retinopathy of prematurity.

Authors:  Hong-Bing Zhang; Xiao-Dong Wang; Kun Xu; Xiao-Gang Li
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

5.  Characteristics of stakeholder involvement in systematic and rapid reviews: a methodological review in the area of health services research.

Authors:  Jonas Feldmann; Milo Alan Puhan; Margot Mütsch
Journal:  BMJ Open       Date:  2019-08-15       Impact factor: 2.692

Review 6.  New Aspects on the Treatment of Retinopathy of Prematurity: Currently Available Therapies and Emerging Novel Therapeutics.

Authors:  Juhee Ryu
Journal:  Int J Mol Sci       Date:  2022-08-01       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.